Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share


Therapeutic Areas: Dermatology | Podiatry | Immunology | Infections and Infectious Diseases

Warts Clinical Trials


A listing of Warts medical research trials actively recruiting patient volunteers. Click on the closest state and city to find more detailed information on a research study in your area.

California

Duarte : City of Hope Medical Center

Patients are needed to participate in a clinical research study of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine, laboratory biomarker analysis, survey administration and medical chart review to evaluate Cancer Survivor or Human Papilloma Virus Infection

Redlands : Call for Information (Investigational Site 0008)

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Spring Valley : Call for Information (Investigational Site 0213)

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Valley Village : Call for Information (Investigational Site 0009)

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Walnut Creek : Call for Information (Investigational Site 0215)

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Connecticut

New Haven : Yale School of Medicine

A clinical trial to evaluate treatments using Occlusive Heat Patch for patients with Verruca (Warts)

District of Columbia

Washington : Georgetown University Hospital

A clinical research study of Quadrivalent HPV for types 6, 11, 16 and 18 for the treatment of Cervical Cancer, Hpv or Warts

Washington : Childrens National Medical Center

A clinical research study of Quadrivalent HPV for types 6, 11, 16 and 18 for the treatment of Cervical Cancer, Hpv or Warts

Georgia

Atlanta : Emory University School Of Medicine

Patients are needed to participate in a clinical research study of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine, laboratory biomarker analysis, survey administration and medical chart review to evaluate Cancer Survivor or Human Papilloma Virus Infection

Kentucky

Bardstown : Call for Information (Investigational Site 0212)

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Massachusetts

Woburn : Call for Information (Investigational Site 0002)

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Michigan

Ann Arbor : University of Michigan

Patients are needed to participate in a clinical research study of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine, laboratory biomarker analysis, survey administration and medical chart review to evaluate Cancer Survivor or Human Papilloma Virus Infection

Nebraska

Omaha : Call for Information (Investigational Site 0004)

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Ohio

Cleveland : Call for Information (Investigational Site 0214)

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Tennessee

Memphis : Saint Jude Childrens Research Hospital

Patients are needed to participate in a clinical research study of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine, laboratory biomarker analysis, survey administration and medical chart review to evaluate Cancer Survivor or Human Papilloma Virus Infection

Texas

Galveston : Call for Information (Investigational Site 0007)

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Utah

South Jordan : Call for Information (Investigational Site 0010)

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Virginia

Newport News : Call for Information (Investigational Site 0001)

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Norfolk : Sentara Norfolk General Hospital

A clinical trial to evaluate treatments using Gardasil for patients with Genital Human Papilloma Virus Infection

Canada

Kirkland : Merck Canada

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Chile

Santiago : Merck Sharp & Dohme (I.A.) Corp.

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Colombia

Bogota : MDS Colombia SAS

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Czech Republic

Praha : Merck Sharp and Dohme s.r.o.

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Denmark

Aalborg : Dermatology Clinic, Vesterbro

A Phase 2 clinical study for patients with Cutaneous Warts

Aarhus C : Marselisborg University Hospital

A Phase 2 clinical study for patients with Cutaneous Warts

Copenhagen NV : Bispebjerg University Hospital

A Phase 2 clinical study for patients with Cutaneous Warts

Glostrup : Merck Sharp & Dohme

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Hellerup : Gentoftte Amtssygehus

A Phase 2 clinical study for patients with Cutaneous Warts

View More »

Odense : Odense University Hospital

A Phase 2 clinical study for patients with Cutaneous Warts

France

Creteil : Hopital Henri Mondor-Dept of Dermatology

Patients are needed to participate in a clinical research study evaluating AP611074 and Placebo for the treatment of Anogenital Warts, Condylomata Acuminata or Human Papillomavirus Infection

Paris : SGS Aster

Patients are needed to participate in a clinical research study evaluating AP611074 and Placebo for the treatment of Anogenital Warts, Condylomata Acuminata or Human Papillomavirus Infection

Israel

Hod Hasharon : Merck Sharp & Dohme Co. Ltd.

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Japan

Chiyoda-Ku, Tokyo : MSD K.K.

A clinical trial seeking patients for a research study for the treatment of Anogenital Human Papilloma Virus Infection or Condyloma Acuminata

Korea, Republic of

Seoul : MSD Korea LTD

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Malaysia

Petaling Jaya : MSD

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Norway

Drammen : MSD Norge A/S

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Spain

Madrid : Merck Sharp and Dohme de Espana S.A.

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Taiwan

Tainan : National Cheng Kung University Hospital

A clinical research study of SR-T100 gel with 2.3% of SM in Solanum undatum plant extract for the treatment of Vulvar Intraepithelial Neoplasia or Genital Warts

Thailand

Bangkok : MSD (Thailand) Ltd.

A Phase 3 clinical study for patients with Human Papillomavirus Infection

Turkey

Istanbul : Merck Sharp & Dohme Ilaclari Ltd. Sti

A Phase 3 clinical study for patients with Human Papillomavirus Infection